J. Charles Jennette | |
---|---|
Born | |
Occupations |
|
Awards |
|
Academic background | |
Education |
|
Alma mater | |
Academic work | |
Institutions |
|
J. Charles Jennette is a physician,nephropathologist,academic,and author. He served as Kenneth M. Brinkhous Distinguished Professor and Chair of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill School of Medicine,and Chief of Pathology and Laboratory Medicine Services at UNC Hospitals from 1999 to 2019. [1]
Jennette's research focuses on understanding the causes of kidney diseases,particularly those induced by inflammatory and immunologic mechanisms,and improving the diagnosis and treatment of these diseases. [1] He has authored and edited books,book chapters and articles in medical journals,and is an editor of four editions of the nephropathology textbook titled Heptinstall's Pathology of the Kidney. He has more than 25 named lectureships including the UNC School of Medicine 2015 Norma Berryhill Distinguished Lecture. [2] He is the recipient of the Order of the Long Leaf Pine Award from the Governor of North Carolina for exemplary service to the State, [3] Distinguished Service Award of the Association of Pathology Chairs, [4] UNC Medical Alumni Distinguished Faculty Award,and Robert H. Heptinstall Lifetime Achievement Award from the Renal Pathology Society. [5]
Jennette served as the founding Secretary Treasurer of the Renal Pathology Society from 1993 until 1998,was elected vice president in 2003,and became president in 2004. He also served as President of the Association of Pathology Chairs from 2008 until 2010. [6]
Jennette received his Bachelor of Science in Zoology from the University of North Carolina at Chapel Hill in 1969 and received his M.D. from the UNC School of Medicine in 1973. From 1973 to 1977 he completed anatomic and clinical pathology residency training at UNC,as well as an immunopathology research fellowship at Scripps Clinic and Research Foundation in La Jolla,California. [1]
Jennette began his faculty career in 1978 as an instructor of pathology at the School of Medicine at the University of Carolina at Chapel Hill. He was appointed assistant professor of pathology in 1978,promoted to associate professor of pathology in 1985,and Professor of Pathology in 1991. From 1999 to 2019,he served as Kenneth M. Brinkhous Distinguished Professor and Chair of Pathology and Laboratory Medicine at the UNC School of Medicine,and as Chief of Pathology and Laboratory Medicine Services at UNC Hospitals. [1]
From 1978 to 2019,Jennette was Director/Executive Director of the UNC Nephropathology Laboratory. He and his faculty associates established this regional nephropathology diagnostic service. [5]
In 2019,Jennette stepped down as Chair of Pathology and Laboratory Medicine. He continues to hold a faculty position as Professor of Pathology and Laboratory Medicine in the Division of Nephropathology,and Professor of Medicine in the Division of Nephrology and Hypertension at UNC Chapel Hill. [6]
Jennette's research encompasses clinical research based on evaluation of data obtained from patient medical records,clinical laboratory data,and pathologic evaluation of kidney biopsy specimens;basic research based on experimental investigations using specimens from patients or animal models of kidney disease;and translational research designed to apply (translate) basic research discoveries into improved diagnosis and treatment of disease in patients. Ronald J. Falk has been a colleague in many of his research works. [7]
Jennette and his associates have performed and published clinical and clinicopathologic studies,and recommendations for the management,diagnosis,and classification of kidney diseases. He was a member of consensus groups that published recommendations for pathologic diagnosis of kidney transplant rejection, [8] focal segmental glomerulosclerosis, [9] IgA nephropathy, [10] membranoproliferative glomerulonephritis, [11] C1q nephropathy, [12] membranous nephropathy, [13] lupus nephritis, [14] and ANCA glomerulonephritis. [15]
In 1994 and 2012,Jennette and his associate Falk led two international consensus conferences that standardized the names and pathologic features of different forms of vascular inflammation (vasculitis). [16] [17] [18]
Jennette and Falk established the Glomerular Disease Collaborative Network (GDCN) in 1985 to promote collaborative research on glomerular disease among UNC faculty in nephrology and nephropathology,along with community practice nephrologists who refer kidney biopsies to UNC for diagnosis. [7]
Clinical and clinicopathologic research projects have utilized GDCN resources,including the article published by Jennette and Falk in The New England Journal of Medicine in 1988,which reported the discovery that one major antigen target of ANCA is myeloperoxidase (MPO-ANCA) and clarified the diverse clinical and pathologic spectrum of ANCA disease,using data and samples obtained through the GDCN. [19] In 1990,they documented that the other major antigen specificity of ANCA is proteinase 3 (PR3-ANCA). [20]
One of Jennette's clinical research associates is his daughter,Caroline Poulton,who is the Director of Research Operations for the UNC Kidney Center. [21] They are co-authors on 20 journal articles that focus on various clinical aspects of kidney disease with the goal of improving patient outcomes,such as a study to optimize treatment outcomes for patients with ANCA vasculitis. [22]
Jennette,in collaboration with Falk,and UNC faculty associates Hong Xiao and Peiqi Hu,and other faculty and trainees,made multiple discoveries about the cellular and molecular mechanisms that cause ANCA disease. He,Falk,and their research associates published the first demonstration that ANCA can activate neutrophils in vitro, [23] and the first in vivo animal model confirming that ANCA antibodies cause glomerulonephritis by inducing glomerulonephritis and vasculitis in mice by intravenous injection of anti-MPO antibodies. [24] This model has been used to make discoveries about the pathogenesis of ANCA disease,including the discovery of a key role for alternative complement pathway activation [25] and C5a receptor engagement,which can be targeted by a novel small molecular inhibitor of C5a receptor (Avacopan). [26] This approach to therapy was FDA-approved for patient care in 2021. [27]
Jennette is married to Yvonne Jennette. They have two daughters,Jennifer Jennette,and Caroline Poulton;and three grandchildren. [28]
Vasculitis is a group of disorders that destroy blood vessels by inflammation. Both arteries and veins are affected. Lymphangitis is sometimes considered a type of vasculitis. Vasculitis is primarily caused by leukocyte migration and resultant damage. Although both occur in vasculitis,inflammation of veins (phlebitis) or arteries (arteritis) on their own are separate entities.
Granulomatosis with polyangiitis (GPA),previously known as Wegener's granulomatosis (WG),after the German physician Friedrich Wegener,is a rare long-term systemic disorder that involves the formation of granulomas and inflammation of blood vessels (vasculitis). It is an autoimmune disease and a form of vasculitis that affects small- and medium-size vessels in many organs but most commonly affects the upper respiratory tract,lungs and kidneys. The signs and symptoms of GPA are highly varied and reflect which organs are supplied by the affected blood vessels. Typical signs and symptoms include nosebleeds,stuffy nose and crustiness of nasal secretions,and inflammation of the uveal layer of the eye. Damage to the heart,lungs and kidneys can be fatal.
Eosinophilic granulomatosis with polyangiitis (EGPA),formerly known as allergic granulomatosis, is an extremely rare autoimmune condition that causes inflammation of small and medium-sized blood vessels (vasculitis) in persons with a history of airway allergic hypersensitivity (atopy).
Polyarteritis nodosa (PAN) is a systemic necrotizing inflammation of blood vessels (vasculitis) affecting medium-sized muscular arteries,typically involving the arteries of the kidneys and other internal organs but generally sparing the lungs' circulation. Small aneurysms are strung like the beads of a rosary,therefore making this "rosary sign" an important diagnostic feature of the vasculitis. PAN is sometimes associated with infection by the hepatitis B or hepatitis C virus. The condition may be present in infants.
Glomerulonephritis (GN) is a term used to refer to several kidney diseases. Many of the diseases are characterised by inflammation either of the glomeruli or of the small blood vessels in the kidneys,hence the name,but not all diseases necessarily have an inflammatory component.
Myeloperoxidase (MPO) is a peroxidase enzyme that in humans is encoded by the MPO gene on chromosome 17. MPO is most abundantly expressed in neutrophils,and produces hypohalous acids to carry out their antimicrobial activity,including hypochlorous acid,the sodium salt of which is the chemical in bleach. It is a lysosomal protein stored in azurophilic granules of the neutrophil and released into the extracellular space during degranulation. Neutrophil myeloperoxidase has a heme pigment,which causes its green color in secretions rich in neutrophils,such as mucus and sputum. The green color contributed to its outdated name verdoperoxidase.
Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies,mainly of the IgG type,against antigens in the cytoplasm of neutrophils and monocytes. They are detected as a blood test in a number of autoimmune disorders,but are particularly associated with systemic vasculitis,so called ANCA-associated vasculitides (AAV).
Membranous glomerulonephritis(MGN) is a slowly progressive disease of the kidney affecting mostly people between ages of 30 and 50 years,usually white people.
Nephritic syndrome is a syndrome comprising signs of nephritis,which is kidney disease involving inflammation. It often occurs in the glomerulus,where it is called glomerulonephritis. Glomerulonephritis is characterized by inflammation and thinning of the glomerular basement membrane and the occurrence of small pores in the podocytes of the glomerulus. These pores become large enough to permit both proteins and red blood cells to pass into the urine. By contrast,nephrotic syndrome is characterized by proteinuria and a constellation of other symptoms that specifically do not include hematuria. Nephritic syndrome,like nephrotic syndrome,may involve low level of albumin in the blood due to the protein albumin moving from the blood to the urine.
Microscopic polyangiitis is an autoimmune disease characterized by a systemic,pauci-immune,necrotizing,small-vessel vasculitis without clinical or pathological evidence of granulomatous inflammation.
Proteinase 3,also known as PRTN3,is an enzyme that in humans is encoded by the PRTN3 gene.
p-ANCA,or MPO-ANCA,or perinuclear anti-neutrophil cytoplasmic antibodies,are antibodies that stain the material around the nucleus of a neutrophil. They are a special class of anti-neutrophil cytoplasmic antibodies.
Rapidly progressive glomerulonephritis (RPGN) is a syndrome of the kidney that is characterized by a rapid loss of kidney function,with glomerular crescent formation seen in at least 50% or 75% of glomeruli seen on kidney biopsies. If left untreated,it rapidly progresses into acute kidney failure and death within months. In 50% of cases,RPGN is associated with an underlying disease such as Goodpasture syndrome,systemic lupus erythematosus or granulomatosis with polyangiitis;the remaining cases are idiopathic. Regardless of the underlying cause,RPGN involves severe injury to the kidneys' glomeruli,with many of the glomeruli containing characteristic glomerular crescents.
Glomerulopathy is a disease that impacts the glomeruli in the nephron,either inflammatory or noninflammatory. Glomerulopathy includes collapsing glomerulopathy,glomerulocystic kidney disease,glomerulomegaly,membranous nephropathy,and tip lesion glomerulopathy.
Pauci-immune vasculitis is a form of vasculitis that is associated with minimal evidence of hypersensitivity upon immunofluorescent staining for IgG. Often,this is discovered in the setting of the kidney.
Necrotizing vasculitis,also called systemic necrotizing vasculitis,is a general term for the inflammation of veins and arteries that develops into necrosis and narrows the vessels.
Focal proliferative nephritis is a type of glomerulonephritis seen in 20% to 35% of cases of lupus nephritis,classified as type III. As the name suggests,lesions are seen in less than half of the glomeruli. Typically,one or two foci within an otherwise normal glomerulus show swelling and proliferation of endothelial and mesangial cells,infiltration by neutrophils,and/or fibrinoid deposits with capillary thrombi. Focal glomerulonephritis is usually associated with only mild microscopic hematuria and proteinuria;a transition to a more diffuse form of renal involvement is associated with more severe disease.
Ronald Jonathan Falk,MD,FACP,FASN is the Nan and Hugh Cullman Eminent Professor and Chair of the Department of Medicine at the University of North Carolina-Chapel Hill (UNC). He is a clinical nephrologist and internationally recognized expert in anti-neutrophil cytoplasmic autoantibody (ANCA)-induced vasculitis and autoimmune kidney disease. His career as a translational physician-scientist spans more than three decades. His clinical practice and translational research focus on characterizing the cell,tissue and physiologic changes in the development of specific autoimmune kidney diseases and developing new approaches for studying autoimmunity,inflammation and basic neutrophil/monocyte biology. He was Chief of the UNC Division of Nephrology and Hypertension from 1993-2015. He co-founded the UNC Kidney Center in 2005 and continues as Co-Director. Falk is a Past-President of the American Society of Nephrology (ASN). Since 2015,he has served as Chair of the Department of Medicine at UNC.
Avacopan,sold under the brand name Tavneos,is a medication used to treat anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Avacopan is a complement 5a receptor antagonist and a cytochrome P450 3A4 inhibitor.
IgM nephropathy or immunoglobulin M nephropathy (IgMN) is a kind of idiopathic glomerulonephritis that is marked by IgM diffuse deposits in the glomerular mesangium. IgM nephropathy was initially documented in 1978 by two separate teams of researchers.